Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation
Titel:
Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation
Auteur:
Fu, Li Gilham, Dean Stotz, Stephanie C. Sarsons, Christopher D. Rakai, Brooke D. Tsujikawa, Laura M. Wasiak, Sylwia Johansson, Jan O. Sweeney, Michael Wong, Norman C.W. Kulikowski, Ewelina